China Releases Q1 Economic Report On Pharmaceutical Industry
This article was originally published in PharmAsia News
China's National Development and Reform Commission (NDRC) has released the Q1 2008 report on the economic progress of key industries. The economic profit of the pharmaceutical industry increased 18.6 percent compared to the same period last year. Chemical medicine output hit 783,000 tonnes while patented Chinese medicine reached 273,000 tonnes, with increases of 11.7 and 10.2 percent, respectively. In the first two months of this year, the pharmaceutical industry realized a profit of 9.41 billion yuan, 50.1 percent higher than the same period in 2007. NDRC forecasts that the growth in output and sales will continue to maintain a level of over 20 percent for this year. With the government's growing investment in health care and tighter industrial supervisory policies, observers are positive about the pharmaceutical industry's outlook. (Click here for more - Chinese Language)
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?